Objective-To investigate whether a lack of glutathione-S-transferase mu (GSTMl) fiction changes in a group of asbestos cement workers, followed up for a long period after the end of exposure. (Occup Environ Med 1994;5l:812-816) 
Results-The lung function in the study group was reduced, compared with reference equations. 23% of the workers had small opacities > 1/0, 29%/o circumscribed pleural thickenings, 14% diffuse thickenings, and 12% obliterated costophrenic angles. 54% of the workers were GSTM1 deficient. They were comparable with the other workers in age, follow up time (median 30 years), and duration of exposure (median 18 years), but had a slightly higher cumulated dose (median 18 v 10 fibre-years) than the others. Neither in radiographical changes nor lung function variables were there any differences between the different GSTM1 groups. The findings were similar when smoking habits and estimated asbestos exposure were taken into account. Conclusions-We could not show that lack of GSTM1 activity was related to an increased risk for radiographical or lung fiction changes in a group of asbestos cement workers, followed up for a long period after the end of exposure.
(Occup Environ Med 1994;5l:812-816) Keywords : glutathione-S-transferase mu, asbestos cement, lung disease Although asbestos related disorders are among the most extensively studied occupational diseases, little is still known about factors that determine individual susceptibility to these conditions. As exposure levels decrease, individual characteristics may well assume a greater importance in determining not only the actual amount of fibre delivered to the lung tissue and retained there, but also the nature of the response. Peribronchiolar fibrosis is the characteristic early lesion after asbestos exposure, found in both animal and human studies.' Based on experimental evidence, it has been suggested that this is a dose-related response, whereas individual susceptibility determines the degree of macrophagic alveolitis, resulting in subsequent fibrosis. 23 Experimental data indicate that active oxygen species may be causally involved in the development of asbestosis.' 4 Data from studies of cell free systems show that active oxygen species may be generated by asbestos fibres themselves. Also, alveolar macrophages that are activated during the phagocytosis of fibres release active oxygen species. At high concentrations active oxygen species are directly cytotoxic to cells of the respiratory tract; also they may cause lipid peroxidation of membrane components. Hence, individual differences in activity of enzymes that are scavengers for active oxygen species may be determinants of the risk for adverse pulmonary effects.
The aim of our study was to investigate whether the activity of one of these scavengers, the enzyme glutathione-S-transferase mu (GSTM1), which is polymorphically distributed in humans, was related to individual differences in adverse outcome of asbestos exposure. The cytosolic glutathione-S-transferases (GSTs) catalyse glutathione conjugation of electrophilic compounds that can be produced from exogenous xenobiotics or arise endogenously during oxidative stress. Rat GSTs 3-3 and 4-4, which are homologous to human GSTM1 (one of the mu class isoenzymes of glutathione transferase), are induced when incubated with xanthine and xanthine oxidase in a superoxide producing system.5
These enzymes also have glutathione peroxidase activity, particularly with DNA hydroperoxides.6 Furthermore, other electrophilic substrates of biological importance like benzo(a)pyrene-7,8-diol-9, 10-epoxide and 4-hydroxyalkenals are also conjugated with glutathione by the rat 3-3 and especially the isoenzymes.6 Allelic variants of GSTM1 were assessed in a group of asbestos cement workers with well characterized individual asbestos exposure, who had been followed up for a long period after the end of exposure. (7, 27) *Median (25, 75 percentiles).
Material and methods
EXPOSED WORKERS
All present and former workers at an asbestos cement plant that had been operating since 1907 were invited to a health examination at the Department of Occupational and Environmental Medicine, Lund when the plant closed down in 1977. In 1984 and 1991 all employees with at least 10 years of employment were invited to other examinations. The examinations included a chest x ray film, spirometry, a work history, and a medical history. We calculated individual cumulative asbestos doses expressed in fibre-years (f-y).7
The average intensity of exposure (f/ml) was also estimated, simply by dividing cumulative dose by employment time. On 15 March 1993 there were 95 male workers with more than 10 years of employment at the plant still alive, who had participated in at least one of the above mentioned health examinations and had had chest x ray films classified according to the International Labour Organisation (ILO) 1980 classification.8 These men formed the study base. Blood samples for determination of genetic polymorphisms for GSTM1 were obtained from 78 (92%) of them. Table 1 shows demographic data and exposure data for participants and non-participants.
CHEST X RAY FILM FINDINGS
The chest x ray films from these workers had been classified according to the ILO 1980 classification by a panel of five readers.9 The median reading from the last film classified was used in our study. The profusion of small opacities regardless of size and shape was considered, as nearly all opacities noted were of irregular shape. Circumscribed and diffuse pleural thickening were noted, regardless of width or extent. Costophrenic angle obliteration was defined as in the ILO standard film. (table 1) . The average intensity of exposure had been somewhat higher in the GSTM1 ( -) group, median 1-0 f/ml, compared with 0-6 f/ml in the GSTM1(+) group (Mann-Whitney, P = 0 05), and thus also the cumulative dose, median 18 v 10 f-y (MannWhitney, P = 0 02). In the GSTM1(-) group the proportion of men with an estimated cumulative dose >20 f-y was 45%, compared with 21% in the GSTM1(+) group (Fisher, P = 0 24).
The distribution of radiographic abnormalities was remarkably similar between the different GSTM1 groups (table 2) . Neither for parenchymal abnormalities nor for pleural abnormalities (circumscribed and diffuse pleural thickening, obliteration of costophrenic angles) were there any differences. The differences in exposure levels between the GSTM1 groups were accounted for in the logistic regression model, but still showed no significant differences between the GSTM1 groups for any of the radiographic changes. The odds ratio (OR) for small opacities of profusion >1/10 in men with GSTM1(-) was 0-8 (95% CI 0-3-2-1), with cumulative dose as the exposure variable.
The two different reference equations used gave somewhat different estimates of vital capacity (VC) (expressed as a percentage of the predicted value). There were no consistent differences between the GSTM1 groups regardless of which reference equation was used, neither when we analysed VC obtained from the last examination (table 2) , nor when we used lung function data obtained at age < 70 (data not shown).
The forced expiratory volume in one second (FEV,) was slightly higher in the GSTM1 (-) group than in the GSTM1 (+) group, but the differences were not significant (table 3) , regardless of whether we used reference equations not corrected for smoking (MannWhitney, P = 0 21) or corrected for smoking (Mann-Whitney, P = 0-41). The results for analyses with age limits were similar. The differences in exposure levels were accounted for in the multiple linear regression model, but showed no significant differences between the GSTM1 groups for either VC or FEVI.
Non-participants had a slightly, but not significantly, higher cumulative dose than participants (table 1) . Radiographic and lung function changes were no more severe than in the participants (table 2) .
Discussion
The question whether the biological response to environmental exposure is modulated by host polymorphism is currently under extensive investigation. The enzymes of interest in the context of asbestos exposure include the GSTs, which may be involved in the inactivation of active oxygen species. Preliminary results have been reported that suggested an over-representation of GSTM1 (-) genotype in a sample of people with asbestos related disease, compared with controls.'4 Studies in populations defined by their asbestos exposure are to our knowledge not previously reported.
Our population was defined on the basis of exposure. The population studied-that is, those with available data on outcome-comprised 78% of all living workers with 10 years of former employment at the plant. Further, the non-participants did not constitute a group with more severe asbestos related disease than the participants. Thus we can assume that the participants are fairly representative of the surviving exposed population. The outcome was studied after the end of exposure, and for all workers > 20 years after the start of employment. Thus, we also assume that sufficient time had elapsed for the development of asbestos related disease in our study group.
The prevalence of genotype GSTM (-) was 54%, which is somewhat higher than an earlier study on 70 chimney sweeps, where GSTM1(-) people comprised 49%.*516 In a previous estimate of the proportion of GSTM1(-) people in Sweden, 54% in a group of 248 examined had a phenotype lacking activity towards trans-stilbene oxide. '7 We could not show any radiographical and lung function differences between men with the genotypes GSTM1(-) and GSTM1(+). The investigated subjects were survivors from a population exposed to asbestos cement. In this population we have found increased risks of respiratory cancer (including mesotheliomas), non-malignant respiratory mortality,7 and a somewhat shorter life span compared with a reference cohort of industrial workers. 18 The population investigated might thus theoretically display an under-representation of people with GSTM1(-), were this genotype strongly associated with premature deaths (related or not with asbestos exposure). The overall prevalence of GSTM1(-) was not lower than expected. Further, we did not find any significantly different distribution of genotypes in older than younger workers, and no overall correlation between age and genotype. Thus, a selective survival bias is not a likely explanation of the present lack of an association between genotype and adverse pulmonary and pleural outcome.
Of the human cytosolic GSTs the GSTA, GSTM and GSTP forms have all been identified in lung tissue.'9 The GSTM1 enzyme probably contributes to only a minor part of the total GST activity in the lung but it may still be crucial for the detoxification of potentially toxic substrates in certain cell populations in the lung. Despite the fact that the GSTMl(-) men had a somewhat higher asbestos exposure than the GSTM1 (+) men, no difference in outcome was found. From the results it can be calculated2930 that there is a probability of 0l10 for a .50% increase in the relative risk of small opacities 1/0 in the GSTM1(-) group. Thus, although our study group was of a moderate size only, the power was reasonable. The corresponding probability estimates for circumscribed pleural thickenings and obliterated costophrenic angles were 0 50 and 0 13. In our study, however, the exposure levels for most workers were low or moderate, and only a small fraction of the men had radiographic changes of ILO grade >.1/1. True differences between GSTM1 groups for more severe parenchymal disease may well exist, but this cannot be evaluated within our study group.
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